Comments on: OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting https://enterabio.com/news/opko-health-and-entera-bio-abstract-for-first-in-class-dual-glp-1-glucagon-tablet-candidate-for-patients-with-obesity-and-metabolic-disorders-selected-for-presentation-at-the-endo-2025-annual-meeting/ Global Leader in Oral Delivery of Therapeutic Proteins Thu, 26 Jun 2025 07:09:31 +0000 hourly 1 https://wordpress.org/?v=6.9.4